Stoke Therapeutics, Inc.

STOK - Company ID 0001623526

Market cap$1.95 B

Rank#2148

Filings588

Stoke Therapeutics, Inc. has filed 588 public company documents between 2014 and 2026. The most frequent type is insider trade (255 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchSTOK overview$1.95 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #2148See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut STOK beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow STOK via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
SC 13D/A	Activist ownership stake (update)	1y ago2024-09-23	-	View filing
SC 13D/A	Activist ownership stake (update)	2y ago2024-04-18	-	View filing
SC 13D/A	Activist ownership stake (update)	5y ago2021-06-29	-	View filing
SC 13D/A	Activist ownership stake (update)	5y ago2020-11-27	-	View filing

Stoke Therapeutics, Inc.

Similar companies to research next

Year